reports
ADMA Biologics Statement on Tariffs
ADMA Biologics Statement on Tariffs Reiterates Strategic Advantage Through Fully U.S.-Based Manufacturing Operations, Commercialization and End-Market Sales, and Vertically Integrated U.S.-Based Supply Chain RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today provided a statement on the recent tariffs put in place and reiterated ADMA’s strategic advantage through fully U.S.-base...
- Jonathan Moreland
OPK OPKO HEALTH INC.
ASPS ALTISOURCE PORTFOLIO SOLUTIONS S.A.
SVRA SAVARA
PNBK PATRIOT NATIONAL BANCORP
FUND ROYCE FOCUS TRUST
WOOF INC.
UAN PETCO HEALTH AND WELLNESS
GAM CVR PARTNERS LP
CATX GENERAL DE ALQUILER DE MAQUINARIA
SUNS PERSPECTIVE THERAPEUTICS
AFCG INC.
SUNRISE REALTY TRUST
AFC GAMMA
INC.
Altisource Announces April 3, 2025 as Distribution Date for Stakeholde...
Altisource Announces April 3, 2025 as Distribution Date for Stakeholder Warrants LUXEMBOURG, March 31, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the distribution of its previously disclosed issuance of Stakeholder Warrants will take place on April 3, 2025 (the “Distribution Date”). Altisource previously announced the proposed issuance under Luxembourg law under the authorized share capital mechanism, which is more commonly ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
LOPE GRAND CANYON EDUCATION INC.
LNDC LANDEC CORP.
HOO HERBALIFE NUTRITION LTD.
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CAAS CHINA AUTOMOTIVE SYSTEMS ADS (N SHARES)
BFAM BRIGHT HORIZONS FAMILY SOLUTIONS INC.
AZO AUTOZONE INC.
ADMA ADMA BIOLOGICS INC
ACU ACME UNITED CORP.
OSTK OVERSTOCK.COM INC.
UVV UNIVERSAL CORP
FDP FRESH DEL MONTE PRODUCE INC.
TATT TAT TECHNOLOGIES LTD.
WMK WEIS MARKETS INC.
KINS KINGSTONE COS. INC.
NC NACCO INDUSTRIES INC. CL A
CHCI COMSTOCK HOLDING COMPANIES
VLGEA VILLAGE SUPER MARKET INC. CL A
LAUR LAUREATE EDUCATION INC. CLASS A
CMCL CALEDONIA MINING CORPORATION
ABT ABBOTT LABORATORIES
BRP BRP GROUP
GRPN GROUPON INC.
CNXC CONCENTRIX
DRVN DRIVEN BRANDS HOLDINGS
ALHC ALIGNMENT HEALTHCARE INC
ADSE ADS TEC ENERGY PLC
KLG_w WK KELLOGG CO
TRVG TRIVAGO N.V.
BG BUNGE LIMITED
IDR IDAHO STRATEGIC RESOURCES INC
DBD DIEBOLD NIXDORF INCORPORATED
CCB CHASE CAPITAL VIII CAP SEC H 8.25%
MNPR MONOPAR THERAPEUTICS INC.
AEVA AEVA TECHNOLOGIES INC.
ORLY OREILLY AUTOMOTIVE INC CDA
Hubzu Enters the Commercial Real Estate Auction Market, Leveraging Its...
Hubzu Enters the Commercial Real Estate Auction Market, Leveraging Its Success in Residential Auctions Helping Commercial Buyers and Sellers Navigate the Market with Hubzu’s Trusted Auction Platform and Expertise LUXEMBOURG, March 24, 2025 (GLOBE NEWSWIRE) -- Hubzu, an Altisource® business unit and a leading online real estate auction marketplace, proudly announces that we have entered the commercial real estate market. Leveraging our extensive experience in real estate transactions and auctions, Hubzu is now offering a more seamless and efficient solution for buying and selling commerc...
Hubzu Expands into Commercial Real Estate Auctions, Bringing its Prove...
Hubzu Expands into Commercial Real Estate Auctions, Bringing its Proven Residential Auction Expertise to the Commercial Market Empowering Commercial Real Estate Buyers and Sellers with Hubzu's Proven Auction Experience and Expertise LUXEMBOURG, March 24, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource®” or the “Company”) (NASDAQ: ASPS), a leading solutions provider for the real estate and mortgage industries, proudly announces that Hubzu®, a leading online real estate marketplace, has entered the commercial real estate market. Leveraging its extensive experienc...
Altisource Announces Fourth Quarter and Full Year 2024 Financial Resul...
Altisource Announces Fourth Quarter and Full Year 2024 Financial Results Fourth Quarter 2024 Service Revenue and Adjusted EBITDA(1) was the Strongest Since the Third Quarter of 2021 and the Third Quarter of 2020, Respectively LUXEMBOURG, March 13, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the fourth quarter and full year 2024. “I am pleased with our full year and fourth quarter 2024 performance as we conti...
Altisource Portfolio Solutions S.A. Schedules Fourth Quarter 2024 Conf...
Altisource Portfolio Solutions S.A. Schedules Fourth Quarter 2024 Conference Call LUXEMBOURG, March 11, 2025 (GLOBE NEWSWIRE) -- On Thursday, March 13, 2025, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the fourth quarter and full year 2024. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its fourth quarter and full year 2024 results. A link to the live audio webcast will be available on Altisou...
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial R...
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA(1) of $164.6 Million, a 309% YoY Increase FY 2024 Adjusted Net Income(2) of $119.2 Million, Compared to $0.7 Million in FY 2023, a 16,810% YoY Increase YE 2024 Total Cash Grew to More than $103 Million, Including $60 Million of Debt Organically Discharged During 2H 2024 ...
Lenders One Unites Members and Providers to Help Drive Profitability a...
Lenders One Unites Members and Providers to Help Drive Profitability and Celebrate 25 Years of Success CANCUN, Mexico, March 03, 2025 (GLOBE NEWSWIRE) -- Lenders One® Cooperative (“L1” or “Lenders One”), a national alliance of independent mortgage bankers, banks and credit unions (collectively “members”), managed by a subsidiary of Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), welcomes members and providers to the L1 Summit, its annual conference at the Hilton Cancun in Cancun, Mexico. During the three-day event, Lenders One members will celebrate the...
ADMA Biologics to Participate in the Raymond James Institutional Inves...
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference RAMSEY, N.J. and BOCA RATON, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 5, 2025, at 11:35 a.m. ET. A live audio webcast of the call will be available und...
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial R...
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 Conference Call Scheduled for March 3, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report fourth quarter and full year 2024 financial results on March 3, 2025, after the U.S. financial markets close. ADMA’s management team will host a...
Altisource Announces Closing of the Previously Announced Exchange and ...
Altisource Announces Closing of the Previously Announced Exchange and Maturity Extension Transactions of the Company’s Term Loans LUXEMBOURG, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, announced the closing of its previously announced exchange transaction with one hundred percent (100%) of lenders under the Company’s senior secured term loans (the “Lenders”) (the “Term Loan Exchange Transactions") and entered into a $12.5 million super ...
Altisource Announces Proposed Distribution of Warrants to Purchase Com...
Altisource Announces Proposed Distribution of Warrants to Purchase Common Stock and Sets February 14, 2025 as the Record Date For Proposed Distribution LUXEMBOURG, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (Nasdaq: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced a proposed issuance under Luxembourg law under the authorized share capital mechanism, which is more commonly referred to as a distribution in the United States (the “Warrant Distribution”), of transferable Warrants (...
Altisource Announces it (1) Anticipates the Record Date to Receive Sta...
Altisource Announces it (1) Anticipates the Record Date to Receive Stakeholder Warrants in Connection With the Previously Announced Debt Exchange Transaction to be February 14, 2025 (2) Entered Into Voting Support Agreements in Favor of Proposals Relating to the Debt Exchange Transaction With Shareholders Holding Approximately 53% of the Company’s Common Stock LUXEMBOURG, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that i...
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provid...
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update FY 2024 Preliminary Unaudited Total Revenue of Approximately $417-425 Million, Exceeding Previous Guidance of $415 Million YE 2024 Total Cash Grew to More than $100 Million, an Increase of Approximately $45 Million Q-o-Q, Notwithstanding $30 Million of Debt Organically Discharged During 4Q 2024 Newly Executed High Titer Plasma Supply Contracts Expected to Provide Foundation for Durable ASCENIV Revenue Growth Through Late 2030s PAS Submitted to the FDA for Approval of Innovative Yield Enhancement Pro...
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference...
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA’s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT. ...
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Fa...
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital Lowers ADMA’s Total Debt to $75 Million, a 29% Reduction Further Supports Earnings Growth Outlook RAMSEY, N.J. and BOCA RATON, Fla., Dec. 20, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced it has repaid $30 million from its original $62...
Altisource Announces it has Entered Into a Transaction Support Agreeme...
Altisource Announces it has Entered Into a Transaction Support Agreement with Lenders Holding Approximately 99% of the Company's Term Loans to Effectuate Exchange, Amendment and Maturity Extension Transactions The Transactions Contemplated by the Agreement Would (a) Reduce the Company’s Current Outstanding Debt Obligations from an aggregate principal amount of $231 Million to, collectively, (i) an up to $110 Million Term Loan, (ii) an up to $50 Million Non-Interest Bearing Exit Fee and (iii) a $12.5 Million Super Senior Credit Facility, (b) Decrease the Company’s Annual Cash and PIK Interes...
First Interstate Bancsystem Inc: 1 director
A director at First Interstate Bancsystem Inc sold 28,550 shares at 33.887USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.